Coronavirus Treatments: Antibody Drugs Could Protect People With Weak Immunity

Coronavirus Treatments: Antibody Drugs Could Protect People With Weak Immunity

There are all kinds of reports about the potential covid treatments that are in the works these days. According to the latest news, it seems that antibody drugs could be able to protect people with weak immunity against the terrible disease triggered by the novel coronavirus.

NBC just reported that there is a considerable portion of this population that remains highly vulnerable to the coronavirus even after three or four vaccine shots.

Monoclonal antibodies fight against covid 19

According to the same article posted by the aforementioned publication, it’s been revealed that a lot of immunocompromised Americans, including people with cancer, autoimmune disorders, and transplanted organs, are impatiently awaiting their ticket that could bring back a sort of normality: “the ability to receive periodic injections of long-acting monoclonal antibodies.”

The same article notes that as research suggests, the treatment could provide them the substantial protection against Covid-19 that in their cases vaccination may not.

It’s been also revealed that the FDA could soon grant emergency authorization to “monoclonal antibodies from drugmaker Regeneron for what is known as pre-exposure prophylaxis, or PrEP, against Covid-19.”


According to the same re[prts, if cleared by the FDA, Regeneron’s therapy could be given as a set of injections every one to three months before potential exposure to the novel coronavirus.

There’s more exciting news about the potential treatments of the disease triggered by the novel coronavirus.

Pfizer addresses experimental pill anti covid

CBS News reports that Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90%. The drugmaker joined the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

For now, the covid treatments used in the U.S. require an IV or injection.

You are probably aware of the fact that competitor Merck’s pill is already under review at the FDA after showing strong initial results, and on Thursday the United Kingdom became the first country to approve it.

Stay tuned for more news and also make sure to stay safe. 

Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.